Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-096341
Filing Date
2024-08-13
Accepted
2024-08-13 16:32:53
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 424b5_atm_08.2024.htm 424B5 469993
2 EX-FILING FEES catx-exfiling_fees.htm EX-FILING FEES 62307
3 GRAPHIC img192937291_0.jpg GRAPHIC 9336
4 GRAPHIC img192937291_1.jpg GRAPHIC 9336
5 GRAPHIC img192937291_2.jpg GRAPHIC 9336
  Complete submission text file 0000950170-24-096341.txt   572676
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279692 | Film No.: 241202228
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)